We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.82%
2 Technology 2.79%
3 Financials 2.26%
4 Consumer Discretionary 1.92%
5 Industrials 1.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIXT
14351
PUT
DELISTED
MIX TELEMATICS LIMITED
MIXT
-11,100
Closed -$124K
BCEL
14352
PUT
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-14,200
Closed -$45K
BKCC
14353
DELISTED
BlackRock Capital Investment Corporation
BKCC
-26,812
Closed -$113K
BKCC
14354
PUT
DELISTED
BlackRock Capital Investment Corporation
BKCC
-25,900
Closed -$109K
BTTX
14355
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
-10,535
Closed -$17.6K
CYT
14356
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
-42,746
Closed -$162K
KBUY
14357
DELISTED
KraneShares CICC China Consumer Leaders Index ETF
KBUY
-12,330
Closed -$241K
ALTU
14358
CALL
DELISTED
Altitude Acquisition Corp
ALTU
-80,800
Closed -$804K
ESEB
14359
DELISTED
Xtrackers J.P. Morgan ESG Emerging Markets Sovereign ETF
ESEB
-10,360
Closed -$194K
CURO
14360
DELISTED
CURO Group Holdings Corp.
CURO
-17,740
Closed -$231K
FAZE
14361
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
-60,636
Closed -$599K
NEPT
14362
CALL
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
-55
Closed -$17K
NEPT
14363
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
-136
Closed -$42K
NEPT
14364
PUT
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
-16
Closed -$5K
ROI
14365
DELISTED
RiskOn International, Inc. Common Stock
ROI
-984
Closed -$68K
LCA
14366
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
-1,503,883
Closed -$14.8M
GRCL
14367
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
-54,383
Closed -$126K
VHAQ.U
14368
DELISTED
Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock
VHAQ.U
-10,547
Closed -$108K
GMBL
14369
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
-3
Closed -$62.1K
ICVX
14370
CALL
DELISTED
Icosavax, Inc. Common Stock
ICVX
-13,800
Closed -$97K
BFIT
14371
DELISTED
Global X Funds Global X Health & Wellness ETF
BFIT
-38,587
Closed -$920K
DMK
14372
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-686
Closed -$21.4K
TSP
14373
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
-141,922
Closed -$1.29M
XBTF
14374
CALL
DELISTED
VanEck Bitcoin Strategy ETF
XBTF
-5,400
Closed -$242K
COMS
14375
CALL
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
-426
Closed -$36K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.